Atlas Trials

First Line Therapy for High Risk Acute GVHD

Clinical trial NCT04061876 · COMPLETED

Trial details

NCT number
NCT04061876
Sponsor
Chinese PLA General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
aGVHDStem Cell Transplant Complications
Start date
2019-08-25
Primary completion
2022-08-01
Enrollment
198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.